MedPath

Eye-acupuncture with rehabilitation therapy for stroke

Not Applicable
Not yet recruiting
Conditions
Hemiplegia for stroke in recovery stage
Registration Number
ITMCTR1900002793
Lead Sponsor
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) aged from 30 to 75 years;
(2) meet the diagnostic criteria of cerebral infarction or cerebral hemorrhage in western medicine;
(3) meet the diagnostic criteria and staging criteria of stroke in traditional Chinese medicine;
(4) cerebral infarction or cerebral hemorrhage occurred within 3 months;
(5) improved BARTHEL index score < 70, improved Rankin scale score >=3;
(6) the patient and his/her family members voluntarily agree to participate in this clinical trial and sign the informed consent.

Exclusion Criteria

(1) lack of clear imaging evidence, such as CT or MRI, or lack of sufficient imaging evidence to determine the diagnosis;
(2) stroke type: patients with progressive stroke and cerebral hemorrhage after cerebral infarction.Patients with impaired consciousness;
(3) patients with mild illness;For patients with mild cerebral stroke or neurological impairment, the score of modified BARTHEL index was >=70.Non-disabling or rapidly improving patients with small strokes, including transient ischemic attack (TIA), reversible ischemic attack (RIND), etc.;
(4) patients with acute stage vascular opening (such as thrombolysis, arterial thrombectomy, super-early thrombus aspiration and stenting, etc.);
(5) those with bleeding tendency; Severe bleeding occurred within 3 months;
(6) patients with severe cardiac insufficiency, patients with atrial fibrillation, patients with cardiac valvular disease or patients after cardiac valve replacement;
(7) patients with other diseases that affect limb movement function, and patients with limb movement dysfunction caused by claudication, rheumatoid arthritis and gouty arthritis before treatment.

Study & Design

Study Type
Treatment study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Fugl-Meyer Assessment (FMA);Activies of Daily Living (ADL);Resting state functional MRI (rs-fMRI);
Secondary Outcome Measures
NameTimeMethod
periinfarct microtubule-associated proteins gene (MAP-2);Western aphasia scale;Montreal Cognitive Assessment;TCM syndrome score;Water swallow test;Brain fuctional remodeling associated protein-43(GAP-43);
© Copyright 2025. All Rights Reserved by MedPath